Insider Stock Trading History of Langer Dennis


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Langer Dennis since year 2005. The trader's CIK number is 1274225. At the time of this reporting, Langer Dennis is the Director of Dicerna Pharmaceuticals Inc . (stock ticker symbol DRNA). See this page for all insider trading activities at Dicerna Pharmaceuticals Inc .

Note that in the past LANGER DENNIS also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Langer Dennis since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-11-16 DRNA Dicerna Pharmaceuticals Inc Sale 23,766 3.52 83,656
2016-02-03 DRNA Dicerna Pharmaceuticals Inc Option Ex 34,722 3.42 118,749
2012-11-29 MYGN Myriad Genetics Inc Option Ex 25,000 13.53 338,250
2012-11-30 MYGN Myriad Genetics Inc Option Ex 45,000 19.06 857,700
2012-11-29 MYGN Myriad Genetics Inc Sale 25,000 29.82 745,500
2012-11-30 MYGN Myriad Genetics Inc Sale 45,000 29.91 1,345,725
2009-02-05 MYGN Myriad Genetics Inc Option Ex 15,000 25.73 386,025
2009-02-05 MYGN Myriad Genetics Inc Sale 15,000 82.72 1,240,725
2008-09-04 MYGN Myriad Genetics Inc Option Ex 5,720 21.49 122,922
2008-09-05 MYGN Myriad Genetics Inc Option Ex 4,280 21.49 91,977
2008-09-04 MYGN Myriad Genetics Inc Sale 5,720 65.73 375,969
2008-09-05 MYGN Myriad Genetics Inc Sale 4,280 63.50 271,780
2007-12-19 MYGN Myriad Genetics Inc Option Ex 10,000 17.23 172,300
2007-12-20 MYGN Myriad Genetics Inc Option Ex 20,000 19.09 381,740
2007-12-19 MYGN Myriad Genetics Inc Sale 10,000 47.52 475,150
2007-12-20 MYGN Myriad Genetics Inc Sale 20,000 47.62 952,380

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Langer Dennis (Director of Dicerna Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.